Advancements across Life Science Sector - iCrowdNewswire

RSS Newsfeeds

See all RSS Newsfeeds

Jul 31, 2017 11:05 AM ET

Advancements across Life Science Sector

iCrowdNewswire - Jul 31, 2017

The “Advancements across Life Science Sector” report has been added to Research and Markets’ offering.

This Genetic Technology TOE depicts the current landscape across life sciences sector. 3D tissue microenvironment tests, protein-based drugs manufacturing, skin testing, cosmetics developments, and crowdsourcing for clinical trials are profiled. The corresponding industry interactions are also depicted.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions.

The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Key Topics Covered:

Technological Innovation Profiles:

– Novel Technologies Being Adopted for Improved Cosmetic Product Development
– 3D Tissue Microenvironments Result in Improved Drug Testing
– Streamlining Manufacturing of Protein-based Drugs
– Digitization of the Clinical Trial Process using Crowdsourcing
– Top 20 Patent Holders in the Area of Skin Testing
– Industry Contacts

For more information about this report visit

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
[email protected]
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Biotechnology (

Via iCrowdNewswire
View Related News >